The evaluation of monocyte lymphocyte ratio as a preoperative predictor in urothelial malignancies: a pooled analysis based on comparative studies

[1]  Ping Yang,et al.  Preoperative Low Lymphocyte-to-Monocyte Ratio Predicts Poor Clinical Outcomes for Patients with Urothelial Carcinoma of the Upper Urinary Tract. , 2018, Urology journal.

[2]  Wen‐Horng Yang,et al.  Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma , 2018, Annals of Surgical Oncology.

[3]  S. Tsai,et al.  PO-095 ICOS: a crucial immunomodulator for development of immunotherapy , 2018, ESMO Open.

[4]  M. Życzkowski,et al.  Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy. , 2018, European review for medical and pharmacological sciences.

[5]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[6]  H. Nishiyama,et al.  Epidemiology of urothelial carcinoma , 2017, International journal of urology : official journal of the Japanese Urological Association.

[7]  Xiaokun Zhao,et al.  Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma , 2017, Oncotarget.

[8]  Xiaokun Zhao,et al.  Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: A systematic review and meta-analysis. , 2017, Oncotarget.

[9]  K. Shimada,et al.  Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy , 2017, Oncology.

[10]  H. Özen,et al.  A critical prognostic analysis of neutrophil–lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma , 2017, International Journal of Clinical Oncology.

[11]  J. Bellmunt,et al.  Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives , 2017, Drugs.

[12]  E. Gallardo,et al.  Recent advances in genitourinary tumors: A review focused on biology and systemic treatment. , 2017, Critical reviews in oncology/hematology.

[13]  Chuan Tian,et al.  The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis , 2017, Scientific Reports.

[14]  Wei Xiong,et al.  Role of tumor microenvironment in tumorigenesis , 2017, Journal of Cancer.

[15]  A. Briganti,et al.  Lymphocyte‐to‐monocyte ratio and neutrophil‐to‐lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy , 2017, Journal of surgical oncology.

[16]  Jian Huang,et al.  Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis , 2016, Oncotarget.

[17]  Guiming Zhang,et al.  Comparison of preoperative neutrophil–lymphocyte, lymphocyte–monocyte, and platelet–lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy , 2016, OncoTargets and therapy.

[18]  Hong-zhao Li,et al.  Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis , 2016, Oncotarget.

[19]  J. Slotta-Huspenina,et al.  The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer , 2016, World Journal of Urology.

[20]  T. Matsuda,et al.  Prognostic impact of perioperative lymphocyte–monocyte ratio in patients with bladder cancer undergoing radical cystectomy , 2016, Tumor Biology.

[21]  Baosheng Li,et al.  Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis , 2015, OncoTargets and therapy.

[22]  A. Zlotta,et al.  Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy , 2015, British Journal of Cancer.

[23]  T. Matsuda,et al.  A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy. , 2015, Japanese journal of clinical oncology.

[24]  Xiaokun Zhao,et al.  Inflammatory myofibroblastic tumor of renal pelvis presenting with iterative hematuria and abdominal pain: A case report. , 2015, Oncology letters.

[25]  H. Muss,et al.  Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis. , 2015, Cancer treatment reviews.

[26]  Xiaokun Zhao,et al.  Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway , 2015, Scientific Reports.

[27]  Qiang Liu,et al.  Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis , 2015, Scientific Reports.

[28]  Tianxin Lin,et al.  CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder. , 2015, The Journal of urology.

[29]  M. Tsuboi,et al.  Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results. , 2015, Japanese journal of clinical oncology.

[30]  D. Ye,et al.  Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy , 2015, Tumor Biology.

[31]  Xiaokun Zhao,et al.  Assessment of the Potential Diagnostic Role of Anaplastic Lymphoma Kinase for Inflammatory Myofibroblastic Tumours: A Meta-Analysis , 2015, PloS one.

[32]  K. Pummer,et al.  Pretreatment lymphocyte–monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma , 2015, Journal of Clinical Pathology.

[33]  Heng-Yi Wu,et al.  Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature , 2014, PloS one.

[34]  Núria Malats,et al.  Inflammatory biomarkers and bladder cancer prognosis: a systematic review. , 2014, European urology.

[35]  D. Mukherji,et al.  Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis , 2014, BMC Urology.

[36]  C. Rosser,et al.  The postoperative morbidity index: a quantitative weighing of postoperative complications applied to urological procedures , 2014, BMC Urology.

[37]  J. Pringle,et al.  Plasticity of melanoma and EMT-TF reprogramming , 2013, Oncotarget.

[38]  J. Väyrynen,et al.  Detailed analysis of inflammatory cell infiltration in colorectal cancer , 2013, British Journal of Cancer.

[39]  David A. Green,et al.  Urothelial carcinoma of the bladder and the upper tract: disparate twins. , 2013, The Journal of urology.

[40]  Yuquan Wei,et al.  Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature , 2012, PloS one.

[41]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[42]  S. Boorjian,et al.  Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy , 2011, BJU international.

[43]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[44]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[45]  F. Schmidt.  Meta-Analysis , 2008 .

[46]  F. Hamdy,et al.  Behavior of urothelial carcinoma with respect to anatomical location. , 2007, The Journal of urology.

[47]  B. Rollins,et al.  Inflammatory chemokines in cancer growth and progression. , 2006, European journal of cancer.

[48]  T. Whiteside,et al.  Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[50]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[51]  A META-ANALYSIS OF THE LITERATURE , 2017 .

[52]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[53]  D. Moher,et al.  Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke , 2010 .

[54]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[55]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[56]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[57]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.